Xin-Wei Dong Selected Research

Airway Remodeling

8/2011	Inhibition of airway inflammation, hyperresponsiveness and remodeling by soy isoflavone in a murine model of allergic asthma.
3/2011	M(3) muscarinic receptor antagonist bencycloquidium bromide attenuates allergic airway inflammation, hyperresponsiveness and remodeling in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xin-Wei Dong Research Topics

Disease

9	Inflammation (Inflammations) 04/2018 - 02/2010
5	Respiratory Hypersensitivity 04/2019 - 03/2011
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2018 - 03/2011
4	Asthma (Bronchial Asthma) 02/2012 - 03/2011
3	Hypersensitivity (Allergy) 04/2019 - 02/2012
3	Neoplasms (Cancer) 01/2018 - 08/2013
2	Ischemia 10/2023 - 05/2017
2	Hyperplasia 04/2018 - 02/2012
2	Lung Neoplasms (Lung Cancer) 01/2018 - 08/2013
2	Fibrosis (Cirrhosis) 05/2017 - 01/2017
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2017 - 01/2017
2	Body Weight (Weight, Body) 01/2017 - 08/2013
2	Pneumonia (Pneumonitis) 09/2012 - 02/2009
2	Airway Remodeling 08/2011 - 03/2011
1	Infarction (Infarctions) 05/2017
1	Hyperlipidemias (Hyperlipidemia) 08/2015
1	Atherosclerosis 08/2015
1	Acute Lung Injury 01/2013
1	Allergic Rhinitis 02/2012
1	Eosinophilia 02/2012
1	Cough 08/2011
1	Bradycardia 03/2011

Drug/Important Bio-Agent (IBA)

4	SmokeIBA 01/2018 - 09/2012
3	OvalbuminIBA 04/2019 - 03/2011
3	Methacholine Chloride (Methacholine)FDA Link 08/2011 - 03/2011
2	GhrelinIBA 10/2023 - 05/2017
2	AntigensIBA 04/2019 - 04/2010
2	Messenger RNA (mRNA)IBA 04/2018 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 04/2018 - 01/2017
2	Bleomycin (Blenoxane)FDA LinkGeneric 05/2017 - 01/2017
2	PolyphenolsIBA 08/2015 - 01/2013
2	p38 Mitogen-Activated Protein KinasesIBA 08/2013 - 01/2013
2	Biomarkers (Surrogate Marker)IBA 08/2011 - 03/2011
2	bencycloquidium bromideIBA 03/2011 - 03/2011
2	Leukotriene B4IBA 04/2010 - 02/2010
1	FlavonesIBA 04/2019
1	Leukotriene D4IBA 04/2019
1	Interleukin-5 (Interleukin 5)IBA 04/2019
1	Immunoglobulin E (IgE)IBA 04/2019
1	Interleukin-4 (Interleukin 4)IBA 04/2019
1	salvianolic acid BIBA 04/2018
1	MucinsIBA 04/2018
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 04/2018
1	MK 2206IBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 05/2017
1	Grape Seed ExtractIBA 05/2017
1	CollagenIBA 05/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2017
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2017
1	InterleukinsIBA 01/2017
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2017
1	Epoxide HydrolasesIBA 01/2017
1	Apolipoproteins E (ApoE)IBA 08/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013
1	GinsenosidesIBA 08/2013
1	Protein Tyrosine PhosphatasesIBA 09/2012
1	EnzymesIBA 09/2012
1	Interleukin-8 (Interleukin 8)IBA 09/2012
1	Protective AgentsIBA 08/2012
1	AllergensIBA 02/2012
1	IsoflavonesIBA 08/2011
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 03/2011
1	Cholinergic Agents (Cholinergics)IBA 03/2011
1	Bronchodilator Agents (Bronchodilators)IBA 03/2011
1	Tiotropium Bromide (Spiriva)FDA Link 03/2011
1	Peroxidase (Myeloperoxidase)IBA 02/2009
1	FlavonoidsIBA 02/2009
1	Superoxide DismutaseIBA 02/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2009
1	LipopolysaccharidesIBA 02/2009

Therapy/Procedure

3	Oral Administration 08/2013 - 08/2011
2	Drug Therapy (Chemotherapy) 01/2017 - 01/2013
2	Therapeutics 08/2013 - 03/2011
1	Inhalation Administration 03/2011